HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)

South Korea · Delayed Price · Currency is KRW

2,755.00

+260.00 (10.42%)

Nov 2, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Headquarters and Bio Business	4.57B	3.41B	384.33M	200.81M	189.68M
Cold Chain Business	58.82B	45.93B	43.50B	14.01B	32.08B
Electronics Business	10.75B	9.00B	9.09B	9.98B	11.47B
Inter-Segment Revenue	-4.57B	-3.41B	-384.33M	-1.54B	-152.71M
Medical Device Business	-	-	-	25.48B	-
Total	69.56B	54.93B	52.59B	48.13B	43.59B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea	68.22B	53.86B	50.98B	46.82B	41.97B
Overseas	1.35B	1.07B	-	-	-
Japan	-	-	1.62B	1.31B	1.58B
United States of America	-	-	-	-	36.97M
Total	69.56B	54.93B	52.59B	48.13B	43.59B